52025-76-0 Usage
Uses
Used in Pharmaceutical Industry:
Cannabielsoin is used as a potential therapeutic agent for various health conditions due to its anti-inflammatory, analgesic, and neuroprotective effects. Ongoing research is exploring its efficacy in treating a range of health issues, contributing to the growing field of cannabinoid-based medicine.
Used in Medical Research:
Cannabielsoin is used as a subject of study in medical research to better understand its potential benefits and role in cannabinoid-based medicine. As regulations around cannabis evolve, there is increasing interest in exploring the therapeutic properties of cannabielsoin and its applications in treating various health conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 52025-76-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,0,2 and 5 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 52025-76:
(7*5)+(6*2)+(5*0)+(4*2)+(3*5)+(2*7)+(1*6)=90
90 % 10 = 0
So 52025-76-0 is a valid CAS Registry Number.
InChI:InChI=1/C21H30O3/c1-5-6-7-8-14-11-16(22)19-17(12-14)24-20-18(19)15(13(2)3)9-10-21(20,4)23/h11-12,15,18,20,22-23H,2,5-10H2,1,3-4H3/t15-,18+,20-,21-/m0/s1
52025-76-0Relevant academic research and scientific papers
METHODS OF SYNTHESIZING CANNABIELSOIN AND ANALOGS THEREOF
-
Paragraph 0059-0063, (2022/02/09)
Disclosed are methods for synthesizing cannabielsoin (CBE) and or analogs thereof. In particular, the present disclosure provides methods for synthesizing CBE or analogs thereof comprising steps of providing a cannabinoid composition that comprises cannabidiol (CBD) or analogs thereof; combining the cannabinoid composition with an agent comprising a ketone functional group; and contacting the cannabinoid composition with an oxidizing agent or exposing the cannabinoid composition to electromagnetic radiation.
Structural revision of a Wnt/β-catenin modulator and confirmation of cannabielsoin constitution and configuration
Monroe, Angelina Z.,Gordon, William H.,Wood, Jared S.,Martin, Gary E.,Morgan, Jeremy B.,Williamson, R. Thomas
supporting information, p. 5658 - 5661 (2021/06/16)
In this report, we revise the structure for a previously reported synthetic product proposed to be the 1R,2S-cannabidiol epoxide and reassign it as cannabielsoin using anisotropic NMR and synthetic chemistry methods. These results provide a direct link to
